2023
Inherited and Acquired Thrombophilias
Abhari P, Paidas M. Inherited and Acquired Thrombophilias. 2023, 114-122. DOI: 10.1002/9781119636540.ch14.Peer-Reviewed Original ResearchThrombophilic conditionsTransient hypercoagulable stateCoagulation factor levelsContext of pregnancyAcquired ThrombophiliaAntifibrinolytic systemsNeonatal outcomesProthrombotic tendencyHypercoagulable stateHormonal changesClinical consequencesThrombotic conditionsFactor levelsPregnancyThrombophiliaMaternalDiagnosis
2012
Inherited and Acquired Thrombophilias
Paidas M. Inherited and Acquired Thrombophilias. 2012, 108-120. DOI: 10.1002/9781119963783.ch15.Peer-Reviewed Original ResearchAntiphospholipid antibody syndromePlacenta-mediated complicationsAntibody syndromeThrombophilic conditionsProthrombin G20210A gene mutationFactor V Leiden mutationBenefits of anticoagulationCornerstone of treatmentProspective cohort studyRecurrent pregnancy lossAdequate clinical trialsV Leiden mutationAcquired ThrombophiliaAntiplatelet therapyCohort studyPregnancy lossThrombophilic mutationsClinical trialsLeiden mutationNatural anticoagulantsRoutine useThrombophiliaGene mutationsAnticoagulationComplications
2006
Inherited Thrombophilias and Early Pregnancy Loss
Langhoff-Roos J, Paidas M, Ku D, Arkel Y, Loekwood C. Inherited Thrombophilias and Early Pregnancy Loss. Medical Intelligence Unit 2006, 229-243. DOI: 10.1007/0-387-34944-8_20.Peer-Reviewed Original ResearchFactor V LeidenThrombophilic conditionsPregnancy complicationsClinical manifestationsV LeidenFirst trimester pregnancy outcomeHeterozygous factor V LeidenIntrauterine growth restrictionLate fetal lossEarly pregnancy lossMaternal thromboembolismThrombogenic mutationsAbruptio placentaePregnancy outcomesProthrombotic conditionsPregnancy lossFetal lossGrowth restrictionAntithrombin deficiencyClinical practiceHeterogeneous groupComplicationsThrombophiliaDominant conditionCurrent knowledge